Telmisartan Plus Tablet 40/12.5mg

Adult dose

For patients not adequately controlling blood pressure with telmisartan alone, this medication should be taken once daily with a beverage, regardless of meals. The Telmisartan/Hydrochlorothiazide combination 40/12.5mg can be administered to patients not adequately controlling blood pressure with 40mg of telmisartan. The Telmisartan/Hydrochlorothiazide combination 80/12.5mg is for patients not adequately controlling blood pressure with 80mg of telmisartan.

Child dose

Safety and efficacy have not been established for pediatric patients under 18 years of age.

This medication should not be used during pregnancy, particularly in the second and third trimesters, as it may cause serious health problems for the fetus or newborn. Patients with allergies to any component of this medication or with specific liver or kidney diseases should avoid its use. Elderly patients or patients with high potassium levels, impaired liver function, or valvular heart disease should use this medication cautiously. As this medication lowers blood pressure, symptoms of hypotension may occur, and rarely, side effects such as skin rash, muscle pain, and gastrointestinal disturbances may arise. Regular blood tests are essential to monitor electrolyte levels, as fluid or electrolyte imbalances may occur. This medication may interact with other blood pressure medications, diuretics, lithium, non-steroidal anti-inflammatory drugs, etc., so if taking other medicines, consult a doctor or pharmacist. If planning a pregnancy or if pregnancy is confirmed, discontinue this medication immediately and consult a doctor; it is also advisable not to take this medication while breastfeeding. In case of overdose, symptoms such as hypotension, electrolyte abnormalities, and dehydration may occur, necessitating an immediate visit to a medical institution. This medication is not recommended for patients under 18 years of age as its safety and efficacy have not been established. Patients may experience dizziness or drowsiness while taking this medication, so caution is needed when driving or operating machinery. Store this medication out of reach of children, and it is advisable not to transfer it to other containers.

Serious side effects

Urticaria, severe swelling (edema), angioedema, chest tightness, difficulty breathing, respiratory distress (including pneumonia and pulmonary edema), liver function abnormalities/liver disorders, skin rash, severe skin adverse reactions (including angioedema and toxic epidermal necrolysis), shortness of breath or difficulty breathing, jaundice, yellowing of skin or eyes, sudden and severe headache, confusion, visual disturbances, paralysis,

Mild side effects

• Hypokalemia
• hyperuricemia
• hyponatremia
• anxiety
• depression
• dizziness
• insomnia
• sleep disturbances
• visual disturbances
• temporary blurred vision

This medication should be stored in a sealed container to prevent air and moisture exposure and kept at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness over time.

Appearance

White/pink oval tablet consisting of two layers, with pink specks on the white layer.

Package unit

30 tablets (10 tablets PTP X 3)